13: Effects of buprenorphine and dexmedetomidine as adjuvants to low dose 0.5% heavy bupivacaine in spinal anaesthesia in patients undergoing transurethral resection of prostate – A comparative study

13:丁丙诺啡和右美托咪定作为低剂量0.5%重布比卡因辅助药物用于经尿道前列腺切除术患者脊髓麻醉的效果——一项比较研究

阅读:1

Abstract

BACKGROUND AND AIM:: Benign prostatic hypertrophy is common in elderly men. Spinal anaesthesia is preferred in transurethral resection of prostate (TURP). This study compares sensory, motor effects and haemodynamics of buprenorphine and dexmedetomidine as adjuvants to low dose 0.5% heavy bupivacine in spinal anaesthesia . METHODS: fter Institutional Ethics Committee approval, a comparative study was conducted which included 30 elderly male patients in the age group 55-75 years belonging to American Society of Anesthesiologists (ASA) grades I and II physical status scheduled for TURP. Patients were randomised into two groups using computer generated random numbers. Group B (n-15) received 2ml 0.5% heavy bupivacine with 45µg buprenorphine and Group D(n-15) received 2ml 0.5% heavy bupivacine with 5µg dexmedetomidine intrathecally.Intra-operatively,following parameters were recorded: Time of onset of T10 , Highest level of motor block sensory analgesia , Time to regression of motor block to Bromage 0 , Duration of analgesia and haemodynamics . RESULTS: A total of 30 patients were included in the study. The demographic data was comparable between the groups .The duration of analgesia in Group-B was 297±43.3 min and in Group-D 412±74.7 min with P value 0.002). There was low incidence of any perioperative complication such as hypotension, bradycardia,nausea and vomiting. CONCLUSION: Addition of buprenorphine 45µg or dexmedetomidine 5µg to 0.5% heavy bupivacaine intrathecally in TURP resulted in prolonged duration of analgesia with haemodynamic stability. Dexmedetomidine has prolonged duration of analgesia with significant p value (0.002).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。